Form 4: Axogen Director Kathy Weiler Receives Annual Equity Grant Valued at $150,000

Axogen, Inc. Director Kathy Johnson Weiler was granted 14,150 restricted stock units valued at $150,000 as part of her annual compensation, vesting in June 2026.

Summary

• Kathy Johnson Weiler, a Director of Axogen, Inc. (AXGN), received an annual equity grant.
• The grant consists of 14,150 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of Axogen, Inc. common stock.
• The number of shares granted is based on a $150,000 valuation as of the grant date.
• The RSUs were granted on June 19, 2025.
• These RSUs will vest on June 19, 2026, which is the one-year anniversary of the grant date.

Sentiment

Score: 6

Explanation: The filing reports a routine annual equity grant to a director, which is a standard compensation practice designed to align management and shareholder interests, indicating stability in corporate governance.

Positives

• The equity grant aligns the financial interests of the director with those of the shareholders, promoting long-term value creation.
• It represents a standard and expected form of compensation for board service, indicating stable corporate governance practices.

Future Outlook

The future outlook involves the vesting of the 14,150 restricted stock units on June 19, 2026, at which point they will convert into shares of Axogen, Inc. common stock.

Management Comments

• The grant represents an annual equity award for service as a Director on the Axogen, Inc. Board of Directors.

Industry Context

This transaction is a routine part of director compensation, common across publicly traded companies to align the interests of board members with those of shareholders. It reflects standard corporate governance practices within the healthcare and medical device industry.

Comparison to Industry Standards

• The grant of restricted stock units as part of director compensation is a common practice in the industry, aligning director incentives with long-term shareholder value.
• While specific comparable companies or projects are not detailed in this filing, this method of compensation is widely adopted by companies similar to Axogen, Inc. to attract and retain qualified board members.

Corporate Governance

Related Party Transactions

• The grant of restricted stock units to Director Kathy Johnson Weiler constitutes a related party transaction, as it involves compensation from Axogen, Inc. to a member of its Board of Directors.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with long-term shareholder value, potentially leading to more shareholder-centric decision-making.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• Vesting of the 14,150 Restricted Stock Units on June 19, 2026.

Key Dates

Keywords

Axogen, AXGN, SEC Form 4, Insider Transaction, Restricted Stock Units, Director Compensation, Equity Grant, Corporate Governance